Highlighting an under-rated clinical development at ASCO20
Embedded deep in any conference database of abstracts are often important findings, which tend to be overlooked by many observers in the rush to focus on the more obvious candidates.
This preview and accompanying thought leader interview explores one such underrated avenue of research.
There is a lot to be said when we have clear signals from our knowledge of the underlying biology in front of us because they inform where therapeutic intervention should be both rational and fruitful.
Is this actually the case in practice?
We dug deeper to find out what’s really happening…
To learn more from our oncology analysis and get a heads up on insights and commentary emerging from the ASCO meeting together with our latest KOL interview, subscribers can log-in or you can click to gain access to BSB Premium Content.
This content is restricted to subscribers